Tag: Menopause / Postmenopause
Premature Ovarian Insufficiency Linked to Autoimmune Diseases
Women diagnosed with POI have increased prevalence of several specific autoimmune diseases
1999 to 2020 Saw Decline in Menopausal Hormone Therapy Use
Decreases seen for women aged younger than 52 years, 52 to <65 years, and 65 years and older, and for Hispanic, non-Hispanic Black, non-Hispanic White women
Gestational Hypertension Tied to Higher Later Risk for Cardiovascular Disease
No associations seen for preeclampsia or eclampsia or gestational diabetes
Hot Flashes May Occur More Often in Second Half of Nightly Sleep
Authors say future research needed to see impact on REM sleep, cardiovascular disease
Review Weighs Treatments for Genitourinary Symptoms of Menopause
Vaginal estrogen, vaginal DHEA, oral ospemifene, vaginal moisturizers may be beneficial for some genitourinary symptoms
2007 to 2023 Saw Decline in Menopausal Hormone Therapy Usage Rates
Rates declined and remained low for women aged 45 to 49, 50 to 54, and 55 to 59 years
Hormone Therapy Tied to Less Biological Aging in Postmenopausal Women
Biological aging discrepancy mediated the association between HT and decreased mortality
Menopausal Transition Linked to Adverse Changes in Lipoprotein Profile
Women experienced greater change in low-density lipoprotein particles from DHS-I to II, with greatest change for premenopausal, perimenopausal women
Elinzanetant Efficacious, Well-Tolerated for Vasomotor Symptoms
Two phase 3 trials showed that elinzanetant reduced VMS frequency and improved VMS severity at weeks 4 and 12
Severe Menopause Symptoms Tied to Cognitive Impairment
Authors say findings show interplay between hormonal, lifestyle, and sociodemographic factors and cognitive health
